OpiCalc Logo

OpiCalc

1332 Clinical Tools

Logo
OpiCalc
AAST Bladder Injury ScaleAAST Renal Injury ScaleAAST Urethral Injury ScaleBPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for doctors. Always free.

Non-Custodial
bedside-Ready

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Response time:
Typically < 24 hours.

Clinical Notice:Calculations must be re-checked and should not be used alone to guide patient care, nor should they substitute for professional clinical judgment. OpiCalc is an auxiliary reference tool for qualified healthcare professionals.

OpiCalc © 2018-2026

•

All Rights Reserved

Validated • Peer-Reviewed • Instant

Recent Journal Updates

BJOGApr 28, 2026
Reduced Fetal Movements Green‐Top Guideline No. 57

Clinical Context

We think this might be relevant to the clinical guidance for SFU Hydronephrosis Grading (Society for Fetal Urology).

British J HaematologyApr 25, 2026
Use of andexanet alfa: A British Society for Haematology position statement

Clinical Context

We think this might be relevant to the clinical guidance for SFU Hydronephrosis Grading (Society for Fetal Urology).

WHO NewsApr 24, 2026
Largest catch-up initiative delivers over 100 million childhood vaccinations

Clinical Context

We think this might be relevant to the clinical guidance for SFU Hydronephrosis Grading (Society for Fetal Urology).

SFU Hydronephrosis Grading

Pediatric & Antenatal Hydronephrosis — Ultrasound Classification

SFU Grading Criteria

Select the grade that best matches the ultrasound appearance:

Select a Grade

Choose the SFU grade matching your ultrasound findings to see management guidance.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Use SFU Hydronephrosis Grading

Prenatal hydronephrosis detected on fetal ultrasound (most common: 1-5% of all pregnancies, 70-80% mild and resolves spontaneously)
Postnatal evaluation of antenatal hydronephrosis (repeat ultrasound at 48 hours to 2 weeks of life, avoid first 48 hours due to physiologic oliguria)
Monitoring known hydronephrosis over time (serial ultrasounds at 1, 3, 6, 12 months, then annually until resolution or stabilization)
Predicting risk of ureteropelvic junction obstruction (UPJO) (SFU 3-4 has 40-70% risk of requiring pyeloplasty vs SFU 1-2 has 5-10% risk)
Guiding need for diuretic renal scan (MAG3 or DTPA): SFU 3-4 or worsening hydronephrosis on serial ultrasounds
Predicting split renal function (SFU 4 and parenchymal thinning predicts ipsilateral function < 40% in 30-50%)
Adult hydronephrosis (obstructing stone, UPJO, malignancy, retroperitoneal fibrosis) — grading predicts need for decompression (nephrostomy, ureteral stent)
Post-pyeloplasty monitoring (SFU grade improvement — successful if grade decreases by ≥ 2 levels or to grade 0-1 by 6-12 months)
Vesicoureteral reflux (VUR) screening: SFU 3-4 with ureteral dilation on ultrasound predicts high-grade VUR (III-V) in 30-40%
Research stratification: clinical trials of prenatal intervention (fetoscopic pyeloplasty), conservative vs surgical management

SFU Grading vs Other Hydronephrosis Classification Systems

Classification SystemNumber of GradesKey Features AssessedPopulationAdvantagesDisadvantages
SFU (Society for Fetal Urology), 19930-4 (5 grades)Renal pelvis dilation, calyceal dilation (few vs all), parenchymal thinning (grade 4 only)Pediatric (prenatal/postnatal) and adultMost widely used, simple, reproducible (inter-observer kappa 0.70-0.80), predicts need for pyeloplasty, correlates with MAG3 drainageDoes not quantify pelvic diameter (mm) — which some studies show predicts outcome better; parenchymal thinning threshold not defined (subjective)
APD (Anterior-Posterior Pelvic Diameter, mm)Mild (10-15 mm), Moderate (15-20 mm), Severe (> 20 mm) — in addition to SFUOnly AP pelvic diameter measured on transverse ultrasound (mm)Primarily prenatal and postnatal (first year)Quantitative, more reproducible than SFU (kappa 0.85), predicts postnatal outcome better than SFU alone (APD > 15 mm = 50% require surgery)Does not assess calyceal dilation or parenchymal thickness (misses high-grade hydronephrosis with mild pelvic dilation but severe caliectasis)
UTD (Urinary Tract Dilation) classification, 2014UTD A1, A2-3, P1, P2, P3 (5 grades for prenatal/postnatal)Pelvis APD, calyceal dilation, parenchymal thickness, ureteral dilation, bladder abnormalitiesPrenatal and postnatal (multidisciplinary — radiology, urology, nephrology)Comprehensive (includes ureter, bladder), validated in large cohorts, better at predicting VUR and obstruction than SFU aloneMore complex (5 grades, multiple parameters), requires more training, less widely adopted than SFU
Onen grading (alternative, 2007)0-3 (4 grades)Parenchymal thickness ratio (affected/normal kidney)Pediatric (UPJO)Focuses on functional parenchyma (better predictor of renal function loss than pelvic or calyceal dilation)Less validated, not widely used, requires measurement of parenchyma (subject to error)

What SFU Grade Does NOT Predict (Limitations)

Obstruction physiology — SFU grade alone does not differentiate between obstructive vs non-obstructive hydronephrosis (e.g., high-grade SFU 3 may drain well on MAG3; low-grade SFU 1 may be obstructed). Diuretic renogram (MAG3) required for obstruction assessment.
Split renal function — SFU 4 with parenchymal thinning correlates with reduced function but cannot quantify (MAG3 required: differential function < 40% is abnormal, < 35% often indication for pyeloplasty).
Vesicoureteral reflux (VUR) — SFU 3-4 may be due to VUR (not obstruction) — requires voiding cystourethrogram (VCUG) for diagnosis. SFU grade does not predict VUR grade well (sensitivity 50-60%).
Etiology — SFU does not distinguish UPJO, VUR, ureterocele, megaureter, posterior urethral valves (PUV), or pruned belly syndrome — requires additional imaging (VCUG, MRI urogram, cystoscopy).
Urinary tract infection risk — SFU 3-4 has higher UTI risk (OR 2.5 vs SFU 0-2) but grade alone insufficient — need VCUG to rule out VUR (most important UTI risk factor).
Need for surgery — 30-40% of SFU 4 improve spontaneously without surgery; 10-15% of SFU 2 worsen and require pyeloplasty. Grade alone insufficient; need serial ultrasounds, MAG3, and symptomatic UTIs to decide.
Adult hydronephrosis due to stone — SFU grading does not predict need for emergency decompression (nephrostomy vs stent) — clinical factors (sepsis, intractable pain, anuria, creatinine rise) override grade.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the Vur Grading to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Urology Tools

VUR Grading
PADUA Prediction Score
GUPI
IIEF-5 / SHIM
CAPRA Score
Guy's Stone Score
OAB-V8
Fournier's Gangrene Severity Index
R.E.N.A.L. Nephrometry Score
BPH Impact Index
Urology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.